Search clinical trials for: Tipranavir (TPV)

Total 1705 results

Boehringer Ingelheim

Terminated

Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients

HIV Infections
Boehringer Ingelheim

Completed

Comparison of the Effect of Tipranavir and Ritonavir or Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Zidovudine in Healthy Volunteers

Healthy
Liquid I.V.
University of Memphis

Not yet recruiting

Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults

Dehydration | Cognitive Performance | Exercise Performance | Exercise Recovery | Rehydration
Liquid I.V.
University of South Carolina; Nutrasource Pharmaceutical and Nutraceutical...

Completed

Clinical Trial to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults

Dehydration | Cognitive Performance | Exercise Performance | Exercise Recovery | Fluid Balance | Rehydration

United States
University of Virginia
Bill and Melinda Gates Foundation; International Centre for Diarrhoeal Disease...

Unknown

Assessment of Community Transmission of Sabin Type 2 Virus in Bangladesh

Vaccine Virus Shedding

Bangladesh
Aga Khan University
National Institutes of Health (NIH); Centers for Disease Control and Prevention and other collaborators

Completed

Polio End-game Strategies - Poliovirus Type 2 Challenge Study

Poliomyelitis

Pakistan
National Jewish Health
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Tailored Treatment to Enhance Risk Perception in Sleep Apnea

Obstructive Sleep Apnea (OSA)

United States
Boehringer Ingelheim

Completed

Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency

Hepatic Insufficiency
Centers for Disease Control and Prevention, China
World Health Organization; Hubei Provincial Center for Disease Control and... and other collaborators

Completed

Serological Survey on Monitoring the Positive Rate After Vaccination of Inactivated Polio Vaccine (IPV)

Poliomyelitis

China
Laboratorios de Biologicos y Reactivos de México...

Unknown

Randomized Clinical Trial to Evaluate Immunogenicity and Safety in Mexicans Newborns

Poliomyelitis

Mexico
Boehringer Ingelheim

Completed

Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy

HIV Infections

France
Vaxtrials S.A.
Bill and Melinda Gates Foundation

Completed

Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life (IPV005)

Polio

Panama
Medtronic Heart Valves

Completed

Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)

Tetralogy of Fallot | Congenital Heart Disease

United States, Canada
Boehringer Ingelheim

Completed

Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers

Healthy
Edwards Lifesciences

Completed

Pulmonic Valve REplacement Multi-discIpline EMEA Registry (PREMIER)

Pulmonary Regurgitation | Pulmonary Insufficiency | Pulmonary Stenosis

Germany, Ireland, Belgium, Israel, United Kingdom, Italy, Poland, Saudi Arabia, Turkey
Boehringer Ingelheim

Completed

Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects

HIV Infections
Boehringer Ingelheim

Completed

Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Population

HIV Infections

Italy
GlaxoSmithKline

Completed

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b
Fidec Corporation
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention

Completed

Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine

Poliomyelitis

Colombia, Dominican Republic, Guatemala, Panama
Serum Institute of India Pvt. Ltd.
PATH

Completed

Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization

Rotavirus Gastroenteritis

India
Boehringer Ingelheim

Completed

Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir

HIV Infections
Taewoong Medical Co., Ltd.
Avania

Active, not recruiting

PULSTA Transcatheter Pulmonary Valve Pre-Approval Study

Heart Diseases | Tetralogy of Fallot | Pulmonary Valve Stenosis | Pulmonary Valve Regurgitation

Germany, Spain, Korea, Republic of, Italy, Netherlands, Turkey
Boehringer Ingelheim

Completed

Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals

HIV Infections

United States, Puerto Rico
Seoul National University Hospital

Completed

A Feasibility Study to Evaluate the Safety and Short-term Effectiveness of Transcatheter Pulmonary Valve (TPV)

Cardiovascular Abnormalities | Pulmonary Valve Insufficiency | Pulmonary Valve Stenosis | Congenital Heart Defects

Korea, Republic of
Boehringer Ingelheim

Completed

Evaluation of the Pharmacokinetic Interaction of Steady State Tipranavir and Ritonavir or Tipranavir and Ritonavir With Single Dose Didanosine in Healthy Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioavailability of Tipranavir/Ritonavir Paediatric Solution Compared to Tipranavir/Ritonavir Capsules in Healthy Female and Male Subjects

Healthy
Boehringer Ingelheim

Completed

Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers

Healthy
Boehringer Ingelheim

Approved for marketing

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

HIV Infections

Belgium, Brazil, Canada, Denmark, El Salvador, Greece, Italy, Portugal, Spain
Boehringer Ingelheim

Completed

Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects

HIV Infections

United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Denmark, France, Germany, Greece, Italy, Mexico, Netherlands, Portugal, Spain, Switzerland, United Kingdom
Boehringer Ingelheim

Completed

Effects of Single-dose and Steady-state TPV/RTV on the Steady-state Pharmacokinetics of Fluconazole in Healthy Adult Volunteers

Healthy
University of California, Los Angeles

Completed

Transcatheter Valve Implantation in Patients With Dysfunctional Left and Right Sided Heart Valves

Eisenmenger Syndrome

United States
Boehringer Ingelheim

Completed

Relative Bioavailability of Tipranavir (TPV)/Ritonavir (RTV) at Steady State Administered as Oral Solutions vs. Capsules in the Fed and Fasted State in Healthy Volunteers

Healthy
Boehringer Ingelheim

Withdrawn

Surveillance Cohort Long-term Toxicity Antiretrovirals in HIV-infected Patients Enrolled in TPV Cohort

HIV Infections
Taewoong Medical Co., Ltd.

Active, not recruiting

Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study

Pulmonary Valve Stenosis | Congenital Heart Defect | Pulmonary Valve; Insufficiency, Congenital

Korea, Republic of
Cancer Institute and Hospital, Chinese Academy...
Guangxi Center for Disease Control and Prevention; National Institute for the...

Completed

The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV) (Sabin IPV)

Poliomyelitis

China
Boehringer Ingelheim

Approved for marketing

Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection

HIV Infections

United States, Australia, Belgium, Denmark, France, Greece, Ireland, Italy, Portugal, South Africa, Switzerland, United Kingdom
Boehringer Ingelheim

Completed

Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV Patients

HIV Infections
Boehringer Ingelheim

Terminated

Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation

HIV Infections

United States, Argentina, Brazil, France, Germany, Italy, Spain
Boehringer Ingelheim

Completed

Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options

HIV Infections

Germany
Boehringer Ingelheim

Completed

3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study

HIV Infections

Netherlands, United States, Canada, Italy, Spain, Australia, Germany, France, United Kingdom
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours

HIV Infections

Spain
Boehringer Ingelheim

Terminated

Effect of Steady State TPV/r on Intracellular Concentrations of Zidovudine and Carbovir for Patients With HIV

HIV Infections
Boehringer Ingelheim

Completed

Effects of Tipranavir (TPV) and Ritonavir (RTV) on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate in Healthy Volunteers

Healthy
Boehringer Ingelheim

Completed

Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients

HIV Infections

Germany, Italy, Spain
GlaxoSmithKline

Completed

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects

Infections, Papillomavirus

Germany, Spain, France
Boehringer Ingelheim

Completed

Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male Subjects

Healthy
Medtronic Cardiovascular

Active, not recruiting

SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial (SMART)

Aortic Valve Stenosis | Aortic Valve Replacement | Symptomatic Aortic Stenosis

United Kingdom, United States, Netherlands, Canada, Israel, Spain, Finland, Denmark, France, Germany, Switzerland, Italy, Portugal
University of Maryland, Baltimore
Bill and Melinda Gates Foundation; Groupe de Recherche Action en Sante

Completed

Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso

Typhoid

Burkina Faso
Boehringer Ingelheim

Completed

Pharmacokinetics of Tipranavir Soft Elastic Capsules (SEDDS) and Ritonavir and Their Effects on Cytochrome P-450 (3A4) in Healthy Volunteers

Healthy
Teva Pharmaceuticals USA
Teva Pharmaceuticals Development, Inc.

Completed

Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Chronic Urticaria

United States

3

Subscribe